Home- Research
- Conferences
- Workshops & Training
- Program
- Overview
- *Innovation Cafe
- Drug Safety
- Counterfeit Drugs
- Valuation & Auditing
- Drug Discovery Innovation
- Drug Development
- Complex Systems & Org. Development
- Semantic Web
- R&D Knowledge Management
- Abstracts
- Speakers
- Allemand, P
- Barrett, J
- Gardner, S
- Gates, P
- Gibbs, A
- Hardy, B
- Henrick, K
- Jautelat, R
- Jordis, U
- Kanagy, J
- Liebman, M
- Montano, B
- Newman, V
- Polsky-Newman, R
- Scoffin, R
- Sharp, M
- Spitzner, J
- Starry, S
- Weintraub, H
- Wikel, J
- Molecular Medicine
- Nanobiotech
- Personalised Medicine
- Exhibition
- Registration
- About
- Overview
- Contact
- Support
- Schedule
|
|
|
|
|
|
|
|
|
| Barry Hardy, InnovationWell Community of Practice Manager |
|
Dr. Barry Hardy obtained his Ph.D. in 1990 from Syracuse University initially working in the area of computational chemistry, biophysics and computer-aided molecular modelling and drug design. Dr. Hardy has been working in the area of electronic communities and conferencing since 1994 and has organised numerous international projects in the area of the chemical, life and medical sciences. He has also developed technology solutions for internet-based conferencing, tutor-supported e-learning, laboratory automation systems and computational chemistry and informatics. Dr. Hardy was a National Research Fellow at the FDA Center for Biologics and Evaluation, a Hitchings-Elion Fellow at Oxford University and CEO of Virtual Environments International.
He recently chaired the EU-supported Eurotron Virtual Conferences in Glycobiology, and is currently managing the InnovationWell and eCheminfo Communities of Practice. He lives in Switzerland where he works with Douglas Connect in the provision of virtual conferencing, community and knowledge management solutions for the life science, pharma and healthcare sectors. He also works closely with Colayer, a Swiss company dedicated to the development of knowledge-sharing collaborative software and social software.
In the area of Knowledge Management (KM) in R&D he is interested in applying KM strategies and methodologies to enabling productivity and successful outcomes in collaborative-based R&D. With Jeff Spitzner (Rescentris) he is currently developing a KM Audit approach to R&D aimed at continuous improvement of the R&D organisation and its support systems. The performance of the organisation and areas of strengths and weaknesses are identified in the Hardy-Spitzner KM in R&D Scorecard. He also directs KM Institute Switzerland dedicated to the provision of professional KM training, workshops and eLearning.
|
| Barry Hardy, InnovationWell Community of Practice Manager |
|
Dr. Hardy obtained his Ph.D. in 1990 from Syracuse University initially working in the area of computational chemistry, biophysics and computer-aided molecular modelling and drug design. Dr. Hardy has been working in the area of electronic communities and conferencing since 1994 and has organised close to 50 international virtual conferences in the area of the chemical, life and medical sciences. He has also developed technology solutions for internet-based conferencing, tutor-supported e-learning, laboratory automation systems and computational chemistry and informatics. Dr. Hardy was a National Research Fellow at the FDA Center for Biologics and Evaluation, a Hitchings-Elion Fellow at Oxford University and CEO of Virtual Environments International.
He recently chaired the EU-supported Eurotron Virtual Conferences in Glycobiology, and is currently managing the InnovationWell and eCheminfo Communities of Practice. He lives in Switzerland where he works with Douglas Connect in the provision of virtual conferencing, community and knowledge management solutions for the life science, pharma and healthcare sectors. He also works closely with Colayer, a Swiss company dedicated to the development of knowledge-sharing collaborative software and social software.
In the area of Knowledge Management (KM) in R&D he is interested in applying KM strategies and methodologies to enabling productivity and successful outcomes in collaborative-based R&D. With Jeff Spitzner (Rescentris) he is currently developing a KM Audit approach to R&D aimed at continuous improvement of the R&D organisation and its support systems. The performance of the organisation and areas of strengths and weaknesses are identified in the Hardy-Spitzner KM in R&D Scorecard.
|
| |
|
|
|
|
|
|
|
|
|
|
